DIFFERENT SUPRASPINAL RESPONSES TO AUTOMATED, REPETITIVE BLADDER FILLING IN PATIENTS WITH OVERACTIVE BLADDER COMPARED TO HEALTHY SUBJECTS - AN FMRI STUDY

被引：0

作者：

Walter, M. ^{[1
]}

Leitner, L. ^{[1
]}

Michels, L. ^{[2
]}

Kollias, S. ^{[2
]}

Freund, P. ^{[3
]}

Liechti, M. ^{[1
]}

Kessler, T. M. ^{[1
]}

Mehnert, U. ^{[1
]}

机构：

[1] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Neurourol, Zurich, Switzerland

[2] Univ Zurich, Univ Zurich Hosp, Inst Neuroradiol, Zurich, Switzerland

[3] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Neurol, Zurich, Switzerland

来源：

NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

183

引用

页码：S158 / S159

页数：2

共 39 条

[31] Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study
Welk, Blayne
McArthur, Eric
BJU INTERNATIONAL, 2020, 126 (01) : 183 - 190
[32] The association between healthy eating index and serum antioxidant indices in patients with different degrees of cataract compared to healthy subjects: a case-control study
Heidari, Naeimeh
Jabbari, Masoumeh
Babashahi, Mina
Nabie, Reza
Jafarabadi, Mohammad Asghari
Arefhosseini, Seyed Rafie
NUTRITION & FOOD SCIENCE, 2021, 51 (02): : 426 - 438
[33] Re: Increased Risk of Dementia among Patients with Overactive Bladder Treated with an Anticholinergic Medication Compared to a Beta-3 Agonist: A Population-Based Cohort Study
Griebling, Tomas L.
JOURNAL OF UROLOGY, 2021, 205 (05): : 1495 - 1495
[34] Re: Increased Risk of Dementia among Patients with Overactive Bladder Treated with an Anticholinergic Medication Compared to a Beta-3 Agonist: A Population-Based Cohort Study Comment
Wein, Alan J.
JOURNAL OF UROLOGY, 2021, 205 (06): : 1827 - 1827
[35] Editorial Comment: Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study
Moreno-Palacios, Jorge
INTERNATIONAL BRAZ J UROL, 2021, 47 (04): : 890 - 891
[36] Re: Results of a Prospective, Randomized, Multicenter Study Evaluating Sacral Neuromodulation with InterStim Therapy Compared to Standard Medical Therapy at 6-Months in Subjects with Mild Symptoms of Overactive Bladder Editorial Comment
Wein, Alan J.
JOURNAL OF UROLOGY, 2015, 194 (04): : 1051 - 1052
[37] A prospective randomised double-blind cross-over dose-titration study to evaluate the cognitive safety profile of tolterodine as compared to oxybutynin in multiple sclerosis patients with a neurogenic overactive bladder: a planned interim analysis
Nagels, G
De Deyn, PP
Vleugels, L
D'hooghe, MB
Van Glabeke, I
Van Laere, K
De Ridder, D
MULTIPLE SCLEROSIS, 2004, 10 (7032): : S152 - S152
[38] Re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9
Lee, So-Ryoung
Park, Byoung-Won
Kim, Jae Heon
EUROPEAN UROLOGY, 2019, 75 (03) : E57 - E58
[39] Reply to So-Ryoung Lee, Byoung-Won Park, and Jae Heon Kim's Letter to the Editor re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9
Gratzke, Christian
Siddiqui, Emad
EUROPEAN UROLOGY, 2019, 75 (03) : E59 - E60

← 1 2 3 4 →